CRNCY(CRNCY)
CRNCY
No analyst ratings available
No analyst price targets available for CRNCY
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2026E | FY2027E | FY2028E | FY2029E |
|---|---|---|---|---|
| Revenue Avg | $175M | $183M | $204M | $125M |
| Low | $157M | $150M | $182M | $112M |
| High | $188M | $207M | $219M | $134M |
| EBITDA Avg | $154M | $171M | $236M | — |
| Low | $143M | $159M | $217M | — |
| High | $161M | $180M | $250M | — |
| EBIT Avg | $92M | $101M | $157M | — |
| Low | $82M | $89M | $138M | — |
| High | $100M | $110M | $171M | — |
| Net Income Avg | $49M | $55M | $91M | — |
| Low | $42M | $47M | $78M | — |
| High | $54M | $60M | $100M | — |
| EPS Avg | $1.36 | $1.52 | $2.53 | — |
| Low | $1.18 | $1.32 | $2.18 | — |
| High | $1.50 | $1.68 | $2.78 | — |
| Analysts (Rev / EPS) | 2 / 1 | 3 / 1 | 1 / 1 | 1 / — |